View of Tofacitinib – the first JAK inhibitor in the treatment of ulcerative colitis. Beginning of the therapeutic era of „small molecules“ in inflammatory bowel disease?

Return to Article Details Tofacitinib – the first JAK inhibitor in the treatment of ulcerative colitis. Beginning of the therapeutic era of „small molecules“ in inflammatory bowel disease?